Among the candidate shown in Fig. 10, p21-activated kinase 2 (PAK2) provided tight grouping and distinct separation of the motility phenotypes and has been reported to be either upregulated or hyperactivated in a variety of human cancers. Here, PAK2 is linked to cancer.